What's Going On With Marvell Technology Stock Friday?
Marvell Technology (MRVL) rebounds after a sharp tech rout as investors return to oversold AI chip stocks. Read technicals and analysis.
Stocks · News reference
This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Analysts initiated bullish coverage on HCA, GRDN, TTC, MRVL and PLSE, setting price targets of $495, $52, $120, $270 and $70.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Marvell Technology, Inc. Announces Conference Call to Review Third Quarter of Fiscal Year 2027 Financial Results
Marvell Technology, Inc. has scheduled a conference call to discuss its financial results for the third quarter of fiscal year 2027.
Micron, AMD, SanDisk Lead AI Stock Bounce as Investors Buy the Dip
Chip stocks rebound in Friday’s premarket, led by SanDisk, Micron and AMD, recovering only part of Thursday’s losses amid AI sector fears.
Pulse Biosciences Presents Six-Month Interim Results from PRECISE-BTN Study
Pulse Biosciences announced positive six-month interim results from its PRECISE-BTN multicenter study evaluating the nPulse Vybrance Percutaneous Electrode System for benign thyroid nodules.
Needham Raises Price Target on Pulse Biosciences to $64
Needham & Co. increased its price target for Pulse Biosciences, Inc. from $58 to $64 while maintaining a Buy rating.
8-K filing — PULSE BIOSCIENCES, INC. (PLSE)
Filed: 2026-11-06 AccNo: 0001437749-26-035410 Size: 183 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits